Ridgeback Capital Investments

Latest statistics and disclosures from Ridgeback Capital Investments's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BCYC, Affimed Therapeutics B V, and represent 100.00% of Ridgeback Capital Investments's stock portfolio.
  • Added to shares of these 2 stocks: BCYC (+$15M), Affimed Therapeutics B V (+$9.3M).
  • Started 2 new stock positions in BCYC, Affimed Therapeutics B V.
  • Reduced shares in these 1 stock: Amr.
  • Sold out of its position in Amr.
  • Ridgeback Capital Investments was a net buyer of stock by $25M.
  • Ridgeback Capital Investments has $25M in assets under management (AUM).
  • Central Index Key (CIK): 0001423994

Tip: Access up to 7 years of quarterly data

Positions held by Ridgeback Capital Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Ridgeback Capital Investments

Ridgeback Capital Investments holds 2 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bicycle Therapeutics Ads (BCYC) 62.2 $15M NEW 844k 18.08
 View chart
Affimed Therapeutics B V 37.8 $9.3M NEW 15M 0.62
 View chart

Past Filings by Ridgeback Capital Investments

SEC 13F filings are viewable for Ridgeback Capital Investments going back to 2010

View all past filings